Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Ubrogepant NCT05125302 · Ubro Peds — Study to Assess Adverse Events and Disease Activity of Oral Ubrogepa… | Migraine | À vérifier | Phase 3 | RECRUITING | Migraine is a common neurological disorder typically characterized by atta… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Elismetrep NCT07674654 · A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | Migraine | À vérifier | Phase 3 | RECRUITING | This is a long-term safety study to evaluate the safety and tolerability o… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| Eptinezumab NCT07191145 · Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (EL… | Migraine | Traitement symptomatique | Phase 3 | NOT_YET_RECRUITING | Most individuals with mild traumatic brain injury (mTBI) experience post-t… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| greater occipital nerve block NCT07763678 · Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater… | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 4 | NOT_YET_RECRUITING | Migraine is one of the most prevalent neurological disorders worldwide and… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| Neurostimulator NCT07719608 · RECLAIM-II — A Pivotal Clinical Study to Evaluate the MySalvia System for the Tr… | Migraine | À vérifier | Non applicable | RECRUITING | The purpose of this pivotal clinical study is to evaluate the safety and e… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| NIMH Rhythms and Blues Study: A Prospective Natural History Study of… NCT05669703 · NCT05669703 | Migraine | Thérapie génique | À vérifier | RECRUITING | Background: Mood disorders, such as bipolar disorder, can have serious eff… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| The Effect of Two Different Massages on Migraine NCT05452330 · NCT05452330 | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | The study aims to compare the effects of connective tissue massage on pain… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| VNS device NCT02791893 · Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness | Sclérose en plaques | Traitement symptomatique | Non applicable | COMPLETED | The researchers propose studying Gulf veterans with Gulf War Illness (GWI)… À vérifier | ClinicalTrials.gov 2026-08-13 14:16:47 | Détail |
| Sham Transcranial direct current stimulation Étude non communiquée | Migraine · Sclérose en plaques | À vérifier | Non applicable | Actif | This research is being done to determine whether transcranial direct curre… À vérifier | ClinicalTrials.gov 2026-08-12 | Détail |
| Greater Auricular Nerve Block Étude non communiquée | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 4 | Prévu | Migraine is one of the most prevalent neurological disorders worldwide and… À vérifier | ClinicalTrials.gov 2026-08-10 | Détail |
| Saline 0.9% Étude non communiquée | Migraine | Traitement symptomatique | Phase 2 | Prévu | The goal of this double-blinded, randomized placebo controlled clinical tr… À vérifier | ClinicalTrials.gov 2026-08-10 | Détail |
| H.P. Acthar Gel NCT01813591 · A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Mig… | Migraine | Immunomodulation · Traitement symptomatique | Phase 2 | COMPLETED | This small study is to investigate the efficacy of Acthar in the treatment… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:17 | Détail |
| Lidocaine Hydrochloride NCT06462781 · LIGHT 1 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treat… | Migraine | Traitement symptomatique | Phase 1 | COMPLETED | This randomized clinical trial will aim to compare the effectiveness of dr… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:17 | Détail |
| antibodies against calcitonin-gene related peptide or its receptor NCT04019496 · Neurophysiology of Prophylactic Treatment in Migraine | Migraine | Traitement symptomatique | À vérifier | COMPLETED | This study aims to improve the pathophysiological understanding of migrain… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Care as usual NCT03395457 · Tertiary Care With or Without Manual Therapy for Chronic Migraine | Migraine | À vérifier | NA | COMPLETED | The aim of this study is to determine if adding manual therapy to care as… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Click Digital Therapeutic NCT06004388 · Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiv… | Migraine | À vérifier | Phase 3 | COMPLETED | Randomized study of two digital therapeutics for the prevention of episodi… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Evaluation of a Mind-body Based Application for the Treatment of Chro… NCT05090683 · NCT05090683 | Migraine | Traitement symptomatique | NA | COMPLETED | We are investigating the effects of a mind-body based mobile application o… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Lasmiditan NCT05903040 · Ditan Acute tReatments: Effectiveness and Tolerability (DART) | Migraine | À vérifier | À vérifier | COMPLETED | The purpose of this study is to evaluate the efficacy and safety of a rang… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| MEDI0618 NCT06602479 · AURORA — A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to… | Migraine | À vérifier | Phase 2 | RECRUITING | The purpose of this Phase 2 study is to evaluate the safety and efficacy o… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| PRESTO — IndoProCaf Effervescent Tablets Effectiveness in Acute Treat… NCT02115269 · PRESTO — IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Mig… | Migraine | À vérifier | À vérifier | COMPLETED | Headaches are a common medical problem that physicians frequently encounte… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Influence of Oliceridine on the Incidence of Postoperative Nausea and… Fentanyl · PMID 42446132 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source As a typical complication, postoperative nausea and vomiting (PONV) usually occurs among patients undergoing general an… | Journal of investigative surgery : the official journa… 2026-08-16 19:22:13 | Source |
| Real-life effectiveness, tolerability, and safety of atogepant: a pro… Atogepant 60 mg · PMID 42532410 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Migraine is the most frequent reason for neurology consultation and has a significant impact on patients at the profess… | Neurologia 2026-08-16 19:22:13 | Source |
| Sanctioning the supply chain: Analyzing US executive orders on tariff… Fentanyl · PMID 41954013 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source This commentary examines the use of trade tariffs embedded in U.S. executive orders issued during the Trump administrat… | Global public health 2026-08-16 19:22:13 | Source |
| Does Propofol-based or Remimazolam-based Anesthesia Impact the Incide… Metoclopramide 10 mg · PMID 41360105 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This study aimed to compare the incidence of postoperative nausea and vomiting (PONV) between propofol-based and remima… | Anesthesia progress 2026-08-16 19:22:12 | Source |
| IV dexamethasone as adjuvant therapy to metoclopramide for acute post… Metoclopramide 10 mg · PMID 41506783 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source We conducted a randomized study to determine if, among emergency department (ED) patients with acute posttraumatic head… | Headache 2026-08-16 19:22:12 | Source |
| Randomized controlled study of telcagepant plus ibuprofen or acetamin… Telcagepant 280 mg · PMID 21457238 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To evaluate the efficacy and tolerability of telcagepant when co-administered with ibuprofen or acetaminophen for the a… | Headache 2026-08-16 19:22:07 | Source |
| Randomized, controlled trial of telcagepant over four migraine attack… Telcagepant 140 mg · PMID 20974601 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) fo… | Cephalalgia : an international journal of headache 2026-08-16 19:22:04 | Source |
| Examining the molecular mechanisms of topiramate in alleviating insul… Migraine and Body Composition · PMID 38308786 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Migraine, a severely debilitating condition, may be effectively managed with topiramate, known for its migraine prevent… | Endocrine 2026-08-16 19:21:59 | Source |
| Head-motion-controlled video goggles: preliminary concept for an inte… Static magnetic helmet · PMID 19670983 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Light-weight, low-profile, and high-resolution head-mounted displays (HMDs) now allow personalized viewing, of a laparo… | Journal of laparoendoscopic & advanced surgical techni… 2026-08-16 19:21:53 | Source |
| Real-World Characteristics and Treatment Patterns of Calcitonin Gene-… Fremanezumab · PMID 42098428 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Understanding real-world calcitonin gene-related peptide monoclonal antibodies' (CGRP mAbs) use in patients with migrai… | Pain and therapy 2026-08-16 19:21:53 | Source |
| Randomized controlled trial of an oral CGRP receptor antagonist, MK-0… Telcagepant · PMID 17914062 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist… | Neurology 2026-08-16 19:21:48 | Source |
| Analysis of the safety and efficacy of single-stage spinal cord stimu… SCS · PMID 42591884 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To evaluate the safety and efficacy of implantation of a one-stage spinal cord stimulation (SCS) system under general a… | IBRO neuroscience reports 2026-08-16 19:21:47 | Source |
| circLDHC controls sertoli cell maturation and metabolic remodeling th… SCS · PMID 42492653 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Sertoli cells (SCs) are crucial for testicular development, transitioning from a proliferative to a metabolically activ… | Molecular and cellular endocrinology 2026-08-16 19:21:47 | Source |
| Dopamine-modified TiCT MXene promotes supporting cell pluripotency an… SCS · PMID 42229301 | Migraine | Remyélinisation indirecte / réparation · Thérapie cellulaire | Publication | PubMed | Voir la publication source Sensorineural hearing loss (SNHL), predominantly resulting from the irreversible loss of cochlear hair cells, remains a… | Biomaterials 2026-08-16 19:21:47 | Source |
| Adjunctive middle meningeal artery embolization is associated with lo… Middle Meningeal Artery embolization · PMID 42190492 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate whether adjunctive middle meningeal artery (MMA) embolization is associated with lower 30-day readmission a… | Clinical neurology and neurosurgery 2026-08-16 19:21:46 | Source |
| A novel technique for middle meningeal artery embolization with proxi… Middle Meningeal Artery embolization · PMID 42595328 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate single-operator outcomes of a standardized proximal Middle Meningeal Artery Embolization (MMAE) technique u… | Journal of cerebrovascular and endovascular neurosurge… 2026-08-16 19:21:46 | Source |
| Glucagon-Like Peptide-1 Receptor Agonists for Patients with Conservat… Middle Meningeal Artery embolization · PMID 42599090 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Medical management options for nontraumatic subdural hematoma (SDH) remain limited, with only atorvastatin demonstratin… | Neurosurgery 2026-08-16 19:21:46 | Source |
| Halting neuron-fibroblast crosstalk disarms tumor and augments immuno… Rimegepant · PMID 42067475 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source Innervation propels tumor progression through intricate mechanisms. Recently, Zhang et al. demonstrated that sensory ne… | Trends in pharmacological sciences 2026-08-16 19:21:43 | Source |
| Novel Application of UHPLC-MS, HRMS, and 2D-NMR for Structural Elucid… eletriptan · PMID 41507031 | Migraine | Neuroprotection | Publication | PubMed | Voir la publication source A stability-indicating UHPLC-MS method was developed to investigate the stress degradation behavior of eletriptan hydro… | Biomedical chromatography : BMC 2026-08-16 19:21:42 | Source |
| Treatment with eptinezumab for migraine prevention in people with chr… ALD403 · PMID 37357842 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This is a summary of three articles describing preventive treatment of migraine in participants with a diagnosis of bot… | Pain management 2026-08-16 19:21:41 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |